NEULEPTIL 10 MG
PERICIAZINE : 10 MG · DIN 01926772 · SEARCHLIGHT PHARMA INC
Health Canada status: MARKETED
What is NEULEPTIL?
NEULEPTIL 10 MG contains PERICIAZINE : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 01926772, held by SEARCHLIGHT PHARMA INC, supplied as CAPSULE for ORAL administration. Health Canada currently lists it as marketed, status dated 27-Jan-2023. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is NEULEPTIL used for?
Adjunctive medication in some psychotic patients; control of residual prevailing hostility, impulsiveness, and aggressiveness.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 01926772 |
|---|---|
| Brand name | NEULEPTIL |
| Generic / active ingredient | PERICIAZINE : 10 MG |
| Manufacturer | SEARCHLIGHT PHARMA INC |
| Strength | 10 MG |
| Dosage form | CAPSULE |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | N05AC01 PERICIAZINE |
| AHFS class | 28:16.08.24 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 27-Jan-2023 |
| Original market date | 1969-12-31 00:00:00 |
How is it administered?
Adults: 5-20 mg AM, 10-40 mg PM. Elderly: Start at 5 mg/day. Children (5+): 2.5-10 mg AM, 5-30 mg PM. Administer orally, major portion of dose in evening to reduce drowsiness.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Not explicitly stated in provided text (standard practice is 15-30°C, but not in snippet).
How is it supplied?
Capsules: Bottles of 100. Oral Drops: 100 mL bottle with calibrated dropper.
Contraindications
Hypersensitivity to phenothiazines; circulatory collapse; comatose states; spinal/regional anesthesia; blood dyscrasias; angle-closure glaucoma; urinary retention; renal/liver insufficiency.
Warnings and precautions
Increased risk of death in elderly patients with dementia. Risk of Neuroleptic Malignant Syndrome, Tardive Dyskinesia, QT prolongation, and Venous Thromboembolism. May impair driving ability.
What can be used instead?
Other Canadian products sharing ATC code N05AC01 PERICIAZINE. 3 of 4 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| NEULEPTIL | 10 MG | DROPS | SEARCHLIGHT PHARMA INC | MARKETED | DIN 01926756 |
| NEULEPTIL | 5 MG | CAPSULE | SEARCHLIGHT PHARMA INC | MARKETED | DIN 01926780 |
| NEULEPTIL | 20 MG | CAPSULE | SEARCHLIGHT PHARMA INC | DORMANT | DIN 01926764 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.